Day: May 21, 2020

Off-Label Prescribing With Limited Evidence: What We Have To Lose

Randomized clinical trials are the core of how government regulators prevent dangerous drugs from reaching patients. That’s for good reason. Though some prescriptions can be made ethically without the backing of a placebo-controlled, double-blind randomized control trial, these situations are and should remain the exception, not the rule.

READ MORE

Subscribe

* indicates required
Email Format